Lv2
168 积分 2022-08-07 加入
Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach
7天前
已完结
Μetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatment
7天前
已完结
MASLD, MASH, and the CKM Spectrum
7天前
已完结
Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease
7天前
已完结
Association of metabolic dysfunction-associated fatty liver disease with kidney disease
7天前
已完结
The role of lysosomes in metabolic and autoimmune diseases
20天前
已完结
Therapeutic Reprogramming toward Regenerative Medicine
26天前
已完结
Chemical-based epigenetic reprogramming to advance pluripotency and totipotency
26天前
已完结
Gasdermins and pyroptosis in the kidney
1个月前
已完结
Rapidly Blocking the Calcium Overload/ROS Production Feedback Loop to Alleviate Acute Kidney Injury via Microenvironment‐Responsive BAPTA‐AM/BAC Co‐Delivery Nanosystem
1个月前
已完结
皖公网安备34019202002308
